COLLEGIUM PHARMACEUTICAL, INC
Company Stats
- Market Cap
- $710.4M
- as of Sep 30, 2026
- Shares Outstanding
- 32.6M
- Free Float
- 72.3%
Income Statement
- Revenue
- $780.6M
- Operating Income
- $179.6M
- Net Income
- $62.9M
- EBITDA
- $183.8M
- Revenue Growth, 3Y
- 18.9%
- FCF Margin, 3Y Avg
- 40.9%
- FCF Margin, Worst Year
- 32.2%
Cash Flow
- Free Cash Flow
- $327.6M
- FCF Yield
- 46.1%
- Owner FCF Yield
- 40.2%
Balance Sheet
- Cash & Equivalents
- $231.3M
Returns & Capital
- Share Repurchases
- $25.1M
- Buyback Yield, 3Y Avg
- 7.5%
- SBC, 3Y Avg
- $33.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $780.6M | $327.6M | 42.0% |
| FY2024 | $631.4M | $203.3M | 32.2% |
| FY2023 | $566.8M | $274.3M | 48.4% |
| FY2022 | $463.9M | $122.6M | 26.4% |
| FY2021 | $276.9M | $101.6M | 36.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back